Truehopes story began with Anthony Stephans desperate attempt to save his bipolar disorder children, Autumn and Joseph. They, like their mom, Debora, and grandfather, Gordon, both victims of suicide, were being swallowed up in the tightening grip of bipolar disorder.
Stephan had exhausted all avenues in his efforts to save his children. When a specialist told him to give up and to plan more funerals, he resolved that if a lifesaving answer existed, God knew it. He prayed ceaselessly, hoping God would have mercy on his broken family.
His answer came when he met David Hardy, an animal feed formulator. Hardy said that the bipolar behavior of Joseph sounded like ear-and-tail-biting syndrome in pigs, which is successfully treated through nutritional supplementation. Stephan knew he had found the answer, and together they designed a nutritional formula that would support mental and physical wellbeing. Autumn and Joseph became well, and have remained so to this day..
An organization was created and named TRUEHOPE, because true hope can only be found in the healing sustenance that God has provided us. No man, company or science can ever replace that which our Creator has provided for us. In seeking to treat the symptom, we often ignore the Source.
The Science Behind the Supplement
Since 1996, scientific researchers and doctors in clinical practice have been studying the effects of EMPowerplus on mental disorders such as bipolar disorder. Results have been very encouraging and significant.
Dr. Bonnie Kaplan, a respected behavioral research scientist and one of the principal researchers on several of the published studies says, If substantiated in controlled trials, the normalization of the mentally ill via nutrient supplementation would be the most significant breakthrough in the field of mental illness since the beginning of time.
Successful Treatment of Bipolar Disorder II and ADHD with a Micronutrient Formula: A Case Study. Rucklidge JJ, Harrison R. CNS Spectrums. 2010 May;15(5):289-95. ABSTRACT:
Bipolar disorder with co-occurring attention-deficit/hyperactivity disorder (ADHD) is a challenge to treat. Ten previous reports have shown potential benefit of a micronutrient treatment (consisting mainly of vitamins and minerals) for various psychiatric symptoms, including mood and ADHD. This case study aimed to investigate the longer term impact of the micronutrients on both psychiatric and neurocognitive functioning in an off-on-off-on (ABAB) design with 1 year follow-up. A 21-year-old female with bipolar II disorder, ADHD, social anxiety, and panic disorder entered an open-label trial using a nutritional treatment following a documented 8 year history of on-going psychiatric symptoms not well managed by medications. After 8 weeks on the formula she showed significant improvements in mood, anxiety, and hyperactivity/impulsivity. Blood test results remained normal after 8 weeks on the formula. She did not report any adverse side effects associated with the treatment. She then chose to come off the formula; after 8 weeks her depression scores returned to baseline, and anxiety and ADHD symptoms worsened. The formula was reintroduced, showing gradual improvement in all psychiatric symptoms. This case represents a naturalistic ABAB design showing on-off control of symptoms. After 1 year, the patient is now in remission from all mental illness. Neurocognitive changes mirrored behavioral changes, showing improved processing speed, consistency in response speed, and verbal memory.
Dr. Charles Popper, psychopharmacologist and psychiatrist at Harvard Universitys McLean Hospital, published a commentary on the Kaplan et al. (2001) paper, in which he reported the results of his clinical experience with EMPowerplus.
Results: Of 22 patients (10 adults, 9 adolescents, 3 pre-adolescents) who clinically met criteria for bipolar disorder, 19 (86%) showed a positive response to the micronutrient treatment. Of 15 patients taking medications, 11 (73%) were able to gradually withdraw from their medications, and were stable taking the micronutrient treatment alone.
Do vitamins or minerals (apart from lithium) have mood-stabilizing effects? Popper CW. Journal of Clinical Psychiatry. 2001 Dec;62(12):933-5.
Study demonstrated a 37% decrease in depression scores and a 45% decrease in mania scores from the start of treatment in a 6.5 month study of 10 children.
The Journal of Alternative and Complementary Medicine: July 2012, 18(7): 678-685. doi:10.1089/acm.2011.0270
A study was done to assess the impact of EMP on emotions and stress related to the 6.3 earthquake on February 22nd 2011 in Christchurch, New Zealand. This study supports micronutrients as an inexpensive and practical treatment for acute stress following a natural disaster with a slight advantage to higher doses
Shaken but unstirred? Effects of micronutrients on stress and trauma after an earthquake: RCT evidence comparing formulas and doses Rucklidge J, Andridge R, Gorman B, Blampied N, Gordon H, Boggis A. Human Psychopharmacol Clin Exp (2012) DOI: 10.1002/hup.224
An 8 week study of 12 adults with diagnosed ADHD showed Significant improvements were noted across informants (self, observer, clinician) on measures of inattention and hyperactivity/impulsivity, mood, quality of life, anxiety, and stress all with medium to very large effect sizes (all ps < .01); however, the mean of inattention remained in a clinical range whereas the means on measures of mood and hyperactivity/impulsivity were normalized. Follow-up data showed maintenance of changes or further improvement for those who stayed on the micronutrients. Effect of micronutrients on behavior and mood in adults with ADHD: evidence from an 8-week open label trial with natural extension. Rucklidge J, Taylor M, Whitehead K. Journal of Attention Disorders. 2011 Jan;15(1):79-91.
Successful treatment of OCD with a micronutrient formula following partial response to Cognitive Behavioral Therapy (CBT): a case study. Rucklidge JJ. Journal of Anxiety Disorders. 2009 Aug;23(6):836-40.
Obsessive Compulsive Disorder (OCD) affects 0.5-2% of young people many of whom are resistant to conventional treatments. This case study describes an 18-year-old male with OCD who first underwent cognitive behavioral therapy (CBT) for a 1-year period with a modest response (his OCD had shifted from severe to moderate). Within a year, his anxiety had deteriorated back to the severe range and he now had major depression. He then entered an ABAB design trial using a nutritional formula consisting mainly of minerals and vitamins (together, known as micronutrients). After 8 weeks on the formula, his mood was stabilized, his anxiety reduced, and his obsessions were in remission. The treatment was then discontinued for 8 weeks, during which time his obsessions and anxiety worsened and his mood dropped. Reintroduction of the formula again improved the symptoms. This case illustrates the importance of considering the effect micronutrients have on mental illness.
Mood and Behavior Improvement
A group of scientists from three Alberta universities and the Alberta Childrens Hospital published the results of 11 unselected children with mood and behavior problems. The diagnoses of the children included attention deficit hyperactivity disorder (ADHD), bipolar disorder, oppositional defiant disorder (ODD), obsessive-compulsive disorder (OCD), Asperger syndrome, generalized anxiety disorder (GAD), Prader-Willi Syndrome depression, anxiety, and rage. The children were assessed for a minimum of 8 weeks on an adult dose of EMPowerplus, which was well-tolerated. Outcomes were measured with the Young Mania Rating Scale (YMRS), the Youth Outcome Questionnaire (YOQ), and the Child Behavior Checklist (CBCL). Results: For all 9 children who completed the trial, the micronutrient treatment was clinically beneficial, and all effect sizes were large (>.8). Improvement was significant on the YOQ (measuring childrens mood, physical symptoms, self-harm behavior, interpersonal relationship problems, social problems, and attention problems), the YMRS (measuring symptoms such as irritability and disruptive aggressive behaviors), and 7 of the 8 CBCL scales (withdrawn behavior, anxious/depressed mood, social problems, thought problems, attention problems, delinquent behavior, and aggressive behavior).
Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. Kaplan BJ, Fisher JE, Crawford SG, Field CJ, Kolb B. Journal of Child and Adolescent sychopharmacology. 2004 Spring;14(1):115-22.
Autism spectrum disorder (ASD) is often accompanied by self-injurious behavior (SIB), aggression, and tantrums, symptoms that have reportedly improved with micronutrient (vitamins and minerals) treatment. The current study took advantage of naturally occurring differences in parental preferences for treatment approaches. The micronutrient group asked for treatment without pharmaceuticals (n=44, aged 2-28 years at entry [M=8.39+5.58]). Their records were matched with those of 44 similar children whose families requested conventional treatment (medication group). Both groups improved on both the Childhood Autism Rating Scale and the Childhood Psychiatric Rating Scale (all p values <0.0001). Both groups also exhibited significant decreases in total Aberrant Behavior Checklist scores, but the micronutrient groups improvement was significantly greater (p<0.0001). SIB Intensity was lower in the micronutrient group at the end of the study (p=0.005), and improvement on the Clinical Global Impressions scale was greater for the micronutrient group (p=0.0029). It is difficult to determine whether the observed changes were exerted through improvement in mood disorder or through an independent effect on autistic disorder. There were some advantages to treatment with micronutrients - lower activity level, less social withdrawal, less anger, better spontaneity with the examiner, less irritability, lower intensity SIB, markedly fewer adverse events, and less weight gain. Advantages of medication management were insurance coverage, fewer pills, and less frequent dosing.
Micronutrients versus standard medication management in autism: a naturalistic case-control study.
Mehl-Madrona L, Leung B, Kennedy C, Paul S, Kaplan BJ.
Journal of Child and Adolescent Psychopharmacology. 2010 Apr;20(2):95-103.